This federal Project Grant award of $161,000.00 from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program supports a pilot study by the University of Connecticut (UConn) to explore communication about sexuality and intimacy among individuals with metastatic breast cancer (MBC) and their partners. The key objectives of the study are to: 1) identify themes in MBC patients' communication about sexuality and intimacy, 2) determine if specific...
This Project Grant award from the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower) provides $182,236 to New York University School of Medicine to adapt and pilot test an evidence-based sexual health communication skills training intervention for prostate cancer patients. The key products and services to be delivered include: Conducting focus groups with prostate cancer patients and interviews with providers to identify barriers and facilitators to patient-provider communication...
The National Cancer Institute (NCI) awarded a $664,259 Project Grant under the Cancer Cause and Prevention Research (CFDA 93.393) program to Duke University. The grant is for the development and evaluation of the "AYA STEPS" digital health intervention, which aims to help adolescent and young adult (AYA) cancer survivors manage their symptoms and improve engagement with post-treatment care. The project involves a randomized controlled trial to assess the efficacy of the AYA STEPS...
This $290,052 Project Grant award from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) supports the development and evaluation of a mobile-optimized intervention called PERCS-YA (Personalized Cancer Support for Young Adults) to reduce worry and distress among young adult cancer survivors. The award will fund stakeholder-engaged refinement of the PERCS-YA intervention, followed by a Phase II efficacy trial utilizing both a...
This $227,941 Project Grant award from the National Cancer Institute's Cancer Cause and Prevention Research program (CFDA 93.393) supports the development and piloting of the "Cancer Care Companion," an electronic health record (EHR) tool to improve communication and self-management for families of children with cancer. The award recipient, The Washington University, will engage parents and pediatric oncology clinicians to co-develop the tool, which will adapt the existing Epic MyChart...
This Project Grant award from the National Cancer Institute (CFDA 93.398 Cancer Research Manpower) provides $222,749 to Rutgers, The State University of New Jersey to develop and pilot test a single-session digital intervention to support adolescent siblings of children with cancer. The key objectives are to: 1) adapt an existing single-session intervention to address the needs of this population, 2) evaluate the feasibility, acceptability, and preliminary outcomes of the intervention, and 3)...
This Project Grant award from the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower) provides $161,432 to The University of Texas MD Anderson Cancer Center to develop and evaluate a virtual, group-based expressive writing intervention for adolescent and young adult cancer survivors (AYACSS). The overarching goal is to enhance the quality of life and reduce stress among this population, who face multiple psychosocial disparities. The award will fund a 2-year research plan with the...
This Project Grant award from the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower) provides $185,693 to the Research Institute at Nationwide Children's Hospital to fund a digital health parent coaching intervention to improve neurodevelopmental outcomes for young childhood cancer survivors in underserved communities. The 5-year project aims to develop and evaluate a technology-enabled program that supports parents of young childhood cancer survivors, who are at high risk of...
This $1,055,984 federal Project Grant award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) will support a longitudinal study examining the reproductive and sexual health trajectories of emerging adult community college students. The awardee, Innovation Research And Training, Inc. (IRT), a woman-owned small business in Durham, North Carolina, will leverage an...
This federal Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) provides $398,207 to The Washington University in St. Louis to develop and test a multilevel intervention to improve interdisciplinary communication quality in low-resource pediatric oncology hospitals. The project aims to: 1) evaluate the relationship between communication quality and structure around patient deterioration, 2) identify strategies to improve communication...
This federal Project Grant award from the National Cancer Institute (CFDA 93.398 Cancer Research Manpower program) provides $273,211 to Connecticut Children's Medical Center to develop, refine, and assess a novel web-based intervention called the Reproductive and Sexual Health Patient Education and Communication Tool (RESPECT). The goal of RESPECT is to improve sexual and reproductive health communication between adolescent and young adult (AYA) oncology patients and their clinicians. The 5-year project will involve stakeholder interviews to guide RESPECT development, proof-of-concept testing with 30 AYA/clinician pairs, and evaluation of preliminary outcomes. This effort aims to address the critical gap in providing AYA cancer patients with vital sexual and reproductive health counseling and resources.